Yahoo Finance

Companion Animal Pharmaceuticals Market to Surpass USD 32 Billion by 2032, Driven by Innovation and Pet Health Advancements

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Companion Animal Pharmaceuticals Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The Companion Animal ...
Seeking Alpha

Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze® (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic ...

DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that the European Commission (EC) has granted marketing authorization for Enrylaze ® (JZP458; a recombinant ...
Seeking Alpha

Jazz Pharmaceuticals Receives CHMP Positive Opinion for JZP458 (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and ...

DUBLIN, July 21, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a ...
Mena FN

Companion Animal Pharmaceuticals Market To Surpass USD 32 Billion By 2032, Driven By Innovation And Pet Health Advancements

(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the companion animal pharmaceuticals market include developing advanced biologics and targeted therapies driven by increased pet ownership and ...